
|Videos|May 7, 2021
Analyzing 24-month data of the PALADIN study
Author(s)David Hutton, OT Staff Reports
Michael A. Singer, MD, speaks on the highlights of his presentation focusing on IOP in the PALADIN 24-month data intravitreal steroid (ILUVIEN).
Advertisement
Michael A. Singer, MD, of the Medical Center Ophthalmology Associates in San Antonio, Texas, speaks on the highlights of his presentation focusing on intraocular pressure (IOP) in the PALADIN 24-month data intravitreal steroid (ILUVIEN), presented during ARVO 2021.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Orbital and retinal microvascular changes in thyroid eye disease
2
iOpeners with Nicole Bajic, MD: Mary Qiu, MD, on tailored NVG pathways
3
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis
4
Long-lived Greenland sharks may point to new approaches for retinal disease
5












































